Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx

Cancer

Volumn 94, Issue 12, 2002, Pages 3169-3178

  Schuller, David E ^a   Grecula, John C ^a   Agrawal, Amit ^a   Rhoades, Chris A ^a   Orr, Debra A ^a   Young, Donn C ^a   Malone, James P ^a   Merz, Meredith ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Chemoradiotherapy; Chemotherapy; Head and neck carcinoma; Radiation therapy

Indexed keywords

CIMETIDINE; CIPROFLOXACIN; CISPLATIN; DEXAMETHASONE; FLUCONAZOLE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CELL COUNT; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HUMAN; HYPOPHARYNX CARCINOMA; INFECTION; INFECTION PREVENTION; MALE; MOUTH CARCINOMA; NAUSEA AND VOMITING; NEUTROPENIA; NEUTROPHIL; OROPHARYNX CARCINOMA; PATIENT COMPLIANCE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CEREBROVASCULAR ACCIDENT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM METASTASIS; OROPHARYNGEAL NEOPLASMS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES;

EID: 0037096964     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10571     Document Type: Article

References (33)

1. Cancer statistics, 1999
2. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on Intergroup Study 0034
3. Combination therapy protocol for stage III and stage IV carcinoma of the oral cavity, oropharynx, and hypopharynx
4. Chemotherapy of patients with recurrent head and neck cancer
5. Do otolaryngologist-head and neck surgeons and/or chemotherapy have a role in the treatment of head and neck cancer?
6. Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group
7. Postoperative adjuvant treatment of advanced head and neck cancer: Wayne State University experience and Southwest Oncology Group Feasibility Trial
8. Adjuvant chemotherapy for advanced head and neck squamous cell carcinoma: Final report of the Head and Neck Contracts Program
9. Combined-modality therapy for head and neck cancer
10. Chemo-radiotherapy vs radiotherapy in patients with locally advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099 (SWOG 8892, RTOG 8817, ECOG 2388)
11. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24
12. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck
13. An intergroup Phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
14. Superiority of five year survival with chemoradiotherapy (CT-RT) vs radiotherapy in patients (Pts) with locally advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) Phase III study: Final report
15. Mortality and morbidity with intraoperative radiotherapy for head and neck cancer
16. IORT using electron beam or HDR brachytherapy for previously unirradiated head and neck cancers
17. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma
18. Intensified regimen for advanced head and neck squamous cell carcinomas
19. Intensification regimen 2 for advanced head and neck squamous cell carcinomas
20. Phase II trial: Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of the head and neck
21. Long-term follow-up on an intensified treatment regimen for advanced resectable head and neck squamous cell carcinomas
22. Clinical toxicity of peripheral nerve to intraoperative radiotherapy in a canine model
23. The Franz Buschke lecture: Late effects of chemotherapy and radiation therapy: A new hypothesis
24. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial
25. Radiotherapy, combined with simultaneous chemotherapy with mitomycin c and bleomycin for inoperable head and neck cancer - Preliminary report
26. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
27. Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer
28. Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with Stage III and IV squamous cell carcinoma of the head and neck
29. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
30. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma
31. Chemo-radiotherapy, as compared to radiotherapy alone, significantly increases disease-free and overall survival in head and neck cancer patients after surgery: Results of EORTC Phase III trial 22931
32. Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the Southwest Oncology Group
33. Incidence, predisposing factors, and outcome of pharyngocutaneous fistulas complicating head and neck cancer surgery